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Abstract
Background—We have previously examined the associations between perfluorooctanoic acid
(PFOA) exposure, birth weight and gestational age in individuals exposed to PFOA-contaminated
residential drinking water from the Little Hocking Water Association (LHWA). In this
investigation, we expand the scope of our analysis to examine the associations between PFOA,
congenital anomalies, labor and delivery complications and maternal risk factors.
Objectives—To compare the incidence of congenital anomalies, labor and delivery
complications and maternal risk factors in neonates and their mothers residing in zip codes with
public water service provided completely, partially or not at all by the LHWA.
Methods—Logistic regression analyses were performed on singleton neonatal birth outcome data
supplied by the Ohio Department of Health to examine the associations between LHWA water
service category and the outcomes of interest. When possible, models were adjusted for maternal
age, preterm birth, neonatal sex, race, maternal education, alcohol use, tobacco use and diabetic
status.
Results—Increased PFOA exposure, as assessed by water service category, was not associated
with an overall increase in the likelihood of congenital anomalies or any specific diagnosis
(Adjusted OR: 1.4, 95%CI: 0.34–3.3). The overall likelihood of labor and delivery complications
was significantly lower among mothers with water service provided by the LHWA, as compared
to mothers not serviced by the LHWA (Adjusted OR: 0.65, 95% CI: 0.46–0.92). A significant
increase in the likelihood of anemia (Crude OR: 11, 95%CI: 1.8–64) and dysfunctional labor
(Crude OR: 5.3 95%CI: 1.2–24) was noted for mothers residing within zip codes serviced by the
LHWA, but the number of reported cases was very small.
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Conclusion—At the levels measured in the LHWA, we conclude that PFOA is not associated
with increased incidence of congenital anomalies and most labor and delivery complications and
maternal risk factors. Additional research is required to assess the observed associations between
PFOA, anemia and dysfunctional labor.
Keywords
Perflurooctanoic Acid; PFOA; Congenital Anomalies; Pregnancy; Labor and Delivery;
Complications; Maternal Risk Factors; Little Hocking; LHWA
INTRODUCTION
Perfluorooctanoic acid (PFOA) and its salts are fully fluorinated eight carbon (C8) organic
compounds that have been utilized for decades in a variety of industrial and commercial
applications such as the production of tetrafluoroethylene and the manufacturing of
protective coatings for carpets, apparel, housewares, and fire-fighting foams [1]. PFOA is
highly water soluble and resists biologic, environmental and photochemical degradation [2].
Global bio-monitoring studies have indicated that PFOA is ubiquitously found in ground
water and wildlife [3–4]. In the general U.S. population, median serum PFOA values have
been measured at 4–5 ng/mL with no significant gender differences [5] and a mean serum
half-life in the range of 2–4 years [6–8].
Rodent studies have shown that chronic PFOA exposure is associated with developmental
toxicity [9–10]. Studies conducted across two generations of rats revealed decreased weight
gain in the offspring of dams who were orally dosed 30 mg/kg of PFOA per day during
gestation [11]. A statistically significant increase in mortality was observed in both male and
female pups in addition to reduced body weight after weaning and throughout the remainder
of the study. Both sexes experienced delays in reaching sexual maturity. Similarly, Lau
confirmed dose-dependent fetal toxicity of PFOA in mice and observed early pregnancy
loss, delayed fetal growth and development, compromised postnatal survival, and sex-
specific alterations in pubertal maturation [12]. Complete resorption of litters was observed
in dams receiving 40 mg/kg of PFOA per day during gestation. Weight gain in dams that
carried pregnancy to term was significantly lower at 20 mg/kg while post-natal survival was
compromised and growth deficits were observed at dosages greater than or equal to 5 mg/kg.
Fetal weight was also significantly reduced at oral dosages as low as 20 mg/kg. Steady-state
serum PFOA concentrations were reached in dams in 7 days and measured approximately
75, 120, 185 and 275 μg/mL at term (18 days) in the 5, 10, 20 and 40 mg/kg dosage groups,
respectively. Subsequent to these initial observations, more recent investigations have
highlighted neurobehavioral deficits resulting from fetal PFOA exposure in addition to
altered inflammatory responses, reduced lymphoid organ weights and altered antibody
synthesis [13].
Many of the reproductive toxicological effects of PFOA exposure in murines result in part
from altered expression of the peroxisome proliferator- activated receptor-alpha (PPARα)
signaling pathway [14–18]. The PPARα pathway plays a major role in maintaining lipid and
glucose homeostasis, regulating inflammation, cell proliferation and differentiation [19–21].
In humans, however, the precise mechanisms by which PFOA and other perfluorinated
compounds may disrupt fetal development are less certain. Human expression of PPARα is
significantly less than that of mice and less sensitive to activation by PFOA [14,22–23].
Furthermore, PPARα-induction of gene targets related to cell or peroxisome proliferation is
a mechanism not shared by human liver cells [24]. As such, PPARα-independent pathways –
most of which are poorly understood – are more likely to contribute to PFOA's toxicological
effects.
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In humans, several studies have explored the relationship between serum PFOA levels and
fetal development by examining outcomes such as birth weight, birth length, head
circumference, and ponderal index [25–29]. Among these investigations, some results have
been consistent (e.g. the lack of an association between PFOA and gestational age), while
others have not (e.g. the negative association between PFOA and birth weight). More
recently, Fei et al. have explored developmental milestones such as gross motor skills and
cognitive abilities in neonates exposed to PFOA during gestation and found no significant
associations [30], but suggested a potential association between population-level PFOA
exposure and reduced fecundity in mothers [31].
Our own analysis of the potential adverse effects of PFOA exposure on birth weight and
gestational age in residents serviced by the Little Hocking Water Association (LHWA) in
Washington County, Ohio revealed no evidence of a negative association [32]. Unlike prior
cohorts that lacked a distinctive source of environmental exposure, residents of the LHWA
had the highest recorded serum levels of PFOA in a general population as a result of public
drinking water contaminated by local industry [33]. Mean serum PFOA levels in a stratified,
random sample of LHWA residents were approximately 80 times higher than those reported
in the general U.S. population [5,34]. Since maternal and neonatal serum samples were not
available prior to the introduction of several PFOA-reducing interventions enacted by the
LHWA in September 2005, our study utilized birth records supplied by the Ohio
Department of Health (ODH) in conjunction with residential public water service category
as an indicator of maternal PFOA exposure and, indirectly, for fetal exposure since PFOA
crosses the placenta [35–36]. This methodology was informed by analyses which
demonstrated that residential drinking water service was the major determinant of elevated
serum PFOA levels in the LHWA and by PFOA sampling surveys conducted by the Ohio
Environmental Protection Agency (Ohio EPA) which revealed a gradient of contamination
across water service categories [33]. Despite potential methodological limitations (e.g.
exposure misclassification), the high levels of PFOA exposure within the LHWA were well
above the range of normal biologic variation and had the distinct advantage of being less
susceptible to confounding by maternal physiology, which limited prior investigations [37].
Since the publication of our original findings, the association between PFOA exposure and
self-reported pregnancy outcome among LHWA residents was reassessed using direct
measurement of maternal serum PFOA levels [38–39]. Although serum was sampled in
2005–2006 after the implementation of exposure-reducing interventions, differences in
mean serum PFOA concentrations were still observed across water service categories with
residents of the LHWA maintaining the highest levels of exposure [38,40]. Residents within
Washington County who were not serviced by the LHWA had serum PFOA levels similar to
those observed in the general populations of western countries while residents in regions
with water service supplied in part by the LHWA (e.g. Belpre) had intermediate levels of
contamination. Furthermore, no apparent association was found between PFOA exposure
and low birth weight or preterm birth [39]. Preeclampsia was weakly associated with PFOA
exposure as were birth defects with exposures above the 90th percentile.
Given the concordance between our original findings with those that directly measured
PFOA levels in the LHWA, and a continued interest in assessing the developmental impact
of PFOA exposure, the current investigation expanded the scope of our prior analysis to
examine the associations between PFOA exposure, congenital anomalies, labor and deliver
complications and maternal risk factors in the same cohort of LHWA neonates and mothers.
Unlike other analyses which were limited by quality concerns related to self-reported
pregnancy outcome, this investigation utilized a dataset with medically validated outcomes
provided by the ODH. The expanded ODH dataset also permitted greater ability to control
for the confounding effect of parity, maternal education (as an indicator of socioeconomic
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status), smoking status, diabetes and other risk factors that may affect birth outcome. In
short, we assessed whether the cumulative incidence of congenital anomalies, labor and
delivery complications and maternal risk factors differed among the various water service
categories of the LHWA.
METHODS
Study Design
This cross-sectional study received approval from the University of Pennsylvania
Institutional Review Board as well as the Institutional Review Board of the Ohio
Department of Health. This study was determined to be exempt from the Health Insurance
Portability and Accountability Act (HIPAA). There was no requirement for informed
consent due to the nature of the de-identified archival data that were analyzed. This study
was also endorsed by the Decatur Community Advisory Committee, a joint partnership
between residents of the Little Hocking and surrounding communities, local healthcare
providers, members of the Ohio EPA and the University of Pennsylvania School of
Medicine. De-identified, record-level, archival data were obtained from the Ohio
Department of Health (ODH) Center for Vital Health Statistics for all births occurring in
Washington County, Ohio from January 1, 2003 until September 1, 2005. This period was
selected as it was prior to the implementation of several interventions designed to reduce
PFOA exposure in the LHWA. January 1, 2003 was chosen as the study start date since it
marked both the beginning of the first full year in which PFOA levels were measured by the
Ohio EPA in the LHWA and the establishment of the relationship between the University of
Pennsylvania and the Little Hocking community through a grant from the Environmental
Justice Program of the NIEHS.
The dataset provided by the ODH was an update of the dataset originally obtained for our
investigation on birth weight and gestational age. Data which appear in the dataset are
medically validated and not self-reported. This validation applies, in general, to the
diagnosis of congenital anomalies, maternal risk factors and labor/delivery complications.
Maternal risk factor data are typically extracted from antepartum medical records which are
transferred to the birthing hospital by the patient's obstetrician or perinatologist upon
presentation and are appended to the hospital birth record. Labor and delivery complications
and congenital anomalies are also recorded in the birth record at or near the time of delivery
by medical personnel. Certificates of birth are transferred directly to the ODH via electronic
submission for all births occurring in the state of Ohio. The ODH collects data in accordance
with the U.S. Standard Certificate of Live Birth and follows the specifications for coding
and key entry provided by the National Center for Health Statistics. After receipt, the ODH
examines certificates for completeness and correctness. For each record the following
variables were included: birth weight, gestational age (based on last menstrual period),
plurality, parity, neonatal sex, race, maternal age, maternal education, paternal education,
maternal tobacco use, maternal alcohol use, maternal risk factors (anemia, cardiovascular
disease, pulmonary disease, diabetes, genital herpes, hyraminos, hemoglobinopathy, chronic
and pregnancy-related hypertension, eclampsia, incompetent cervix, previous preterm or
small for gestational age, previous infant >4000g, renal disease, Rh Sensitization, uterine
bleeding), labor and delivery complications (febrile, meconium, membrane rupture,
abruption placenta, placenta previa, excessive bleeding, seizure, precipitous labor, prolonged
labor, dysfunctional labor, breech, cephalopelvic disproportion, cord prolapsed, anesthetic
complications, fetal distress), congenital anomalies (anencephalus, spina bifida,
hydrocephalus, microcephalus, CNS anomaly, heart malformation, circulatory anomaly,
rectral atresia, trachea-esophageal fistula, omphalocele, gastrointestinal anomaly, renal
agenesis, urogenital anomaly, cleft lip, polydactyly, club foot, diaphragmatic hernia,
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musculoskeletal anomaly, Down's Syndrome, chromosomal anomaly) and zip code of the
mother's residence.
Public Water Service Categories
Water service categories and the methodology utilized for their creation are identical to our
prior study on birth weight and gestational age. As noted, residents of Washington County
are serviced by several local public water facilities: the LHWA, Belpre Water, Marietta
Water and Warren Water. On the basis of public water supply, PFOA sampling of water
distributed by these facilities and serum sampling conducted between 2005–2006, the zip
codes in Washington County were divided into three categories. The first category obtained
public water service exclusively from the LHWA. This category (“LHWA Only”)
comprised the zip codes of 45724, 45742 and 45784. The second category (“Partial
LHWA”) included zip codes with water service in part from the LHWA, the Belpre Water
System, and others. This category comprised zip codes 45712, 45713, 45714, 45729 and
45787. The third category comprised the zip codes in Washington County entirely outside
the service area of the LHWA or Belpre Water System (“No LHWA”). Zip codes in this
category were: 43787, 45711, 45715, 4523, 45734, 45744, 45745, 45746, 45750, 45767,
45768, 45773, 45786, 45788, and 45789. The major suppliers of public drinking water to zip
codes in this category were Marietta Water and Warren Water.
Results of PFOA sampling conducted by the Ohio EPA were available for several of the
public water facilities in Washington County as were serum sampling results from 2005–
2006(Table 1). Water sampling results indicated substantial PFOA contamination in the
LHWA and, to a lesser extent, Belpre Water. The Ohio EPA did not sample other public
water systems where, in its opinion, there was no prospect of PFOA contamination. In the
cases of zip codes completely and partially serviced by the LHWA, data reflect mean levels
of multiple samples taken during 2002–2005. For zip codes not serviced by the LHWA in
which PFOA contamination did not occur, sampling took place in 2007. A small number of
residents in Washington County also use private wells for their residential water. Surveys
conducted by the Ohio EPA indicated that PFOA levels in water from private wells were on
the order of 12.4 ppb ± 6.9 (mean ±SD). Detectable levels in private wells followed the
general pattern of the distribution observed in public water supplies with the highest levels
of PFOA found in the zip codes comprising the Little Hocking water service area.
Classification by public water service was also informed by our previous investigation of a
stratfied random sample of residents from the LHWA service area and by a subsequent
serum analysis performed by the C8 Health Project between 2005–2006. Our findings
demonstrated that residential drinking water service was the major determinant of serum
PFOA levels with a smaller contribution arising from the consumption of locally-grown
fruits and vegetables. Air exposure played no discernable role. The median serum PFOA
level within this random sample was 354 ppb. Home use of a carbon-based water filter
reduced PFOA levels by about one quarter, but 70% of residents had serum levels in excess
of 200 ppb. The only significant occupational contribution was from work in production
areas at a fluoropolymer manufacturing facility, which employed mostly males [33].
Similarly, in 2009, the C8 Health Project reported on serum PFOA measurements taken
from a volunteer sample of residents serviced by the LHWA and Belpre water systems.
Median values were 132.5 ppb and 27.1 ppb, respectively [40]. The observed gradient in
serum PFOA measurements mirrors the gradient in environmental exposure (Table 1).
Study Population
We examined the incidence of congenital anomalies, labor and delivery complications and
maternal risk factors in 1548 live born neonates which constituted 99.5% of the records used
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in our prior investigation on birth weight and gestational age. Neonates were included in this
study if they were born to mothers residing in Washington County, Ohio between January 1,
2003 and September 1, 2005, had complete records for the requested covariates and if they
were singleton births. Of the confirmed 1589 singleton births in the dataset, 41 (2.6%)
lacked information on one or more of the requested covariates and were censored from
further analysis. 1 of 41 (2.4%) of these censored neonates was diagnosed with a congenital
anomaly, 17 of 41 (41.6%) were born to mothers who experienced a labor and delivery
complication and 19 of 41 (46.3%) were born to mothers diagnosed with a risk factor. Of the
19 mothers diagnosed with a risk factor, 9 (47.3%) experienced a complication during labor
and delivery. The incidence of congenital anomalies, labor and delivery complications and
maternal risk factors among censored observations were not significantly different from the
incidence rates calculated for neonates included in the study (p=0.76, p=0.83 p=0.30,
respectively).
Statistical Analysis
Data are presented as frequencies and percents. To compare birth outcomes across the
exposure groups (e.g. water service categories) logistic regression analysis was performed to
calculate odds ratios and 95% confidence intervals across the levels of each covariate.
Unadjusted or “crude” odds ratios are provided for individual diagnoses. Multiple logistic
regression models were used to compare the odds ratios of aggregate outcome for the overall
incidence of congenital anomalies, labor and delivery complications and maternal risk
factors between each water service category after adjusting for race, parity, preterm birth,
maternal age, maternal education (as an indicator of socioeconomic status), diabetic status,
and tobacco and alcohol use during pregnancy. To address the phenomenon of separation in
the data set, a bias reduction method was utilized to generate finite parameter estimates [41–
42]. An exact binomial test was utilized to assess differences in cumulative incident rates
between water service categories and national averages. Maternal age was stratified into
categories that have known associations with gestational outcome and which are commonly
used in the literature [43–47]. With alpha set at 0.05, this investigation had an 80% power of
detecting a true odds ratio of approximately 2.7 when comparing the likelihood of
congenital anomalies between LHWA Only and No LHWA water service categories.
Similarly, this study had an 80% power of detecting true odds ratios of 1.6 when comparing
either the likelihood of labor and delivery complications or maternal risk factors across
strata. All statistical analyses were performed using STATA 9.2 (StataCorp., College
Station, TX).
RESULTS
The 1548 singleton neonates included in this study comprised 773 (50%) males and 775
(50%) females. The demographics according to race were as follows: White, 1512 (97.7%);
African-American, 19 (1.2%); Other, 17 (1.1%). Mean age of mothers was 26.1 ± 5.6 years
(range 14–44 years). Seventy-six percent of newborns (N=1171) were born to mothers
residing in zip codes without service from the LHWA (No LHWA); 13% of newborns
(N=209) were born to mothers residing in zip codes partially serviced by the LHWA (Partial
LHWA); and 11% of newborns (N=168) were born to mothers residing within zip codes
exclusively serviced the LHWA (LHWA Only). Descriptive data for each water service
category are provided (Table 2).
Congenital Anomalies
Of the 1548 records that were analyzed, 3 of 168 (1.8%) neonates born to LHWA Only
mothers were diagnosed with one or more congenital anomalies (1 heart malformation, 1
circulatory malformation, 1 club foot) between January 2003 and August 2005. This
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compares to 23 of 1171 (2.0%) neonates with one or more congenital anomalies reported in
the No LHWA water service category (Adjusted OR: 1.1, 95%CI: 0.34–3.3) and 4 of 209
(1.9%) neonates within the Partial LHWA (Adjusted OR: 1.1, 95%CI: 0.40–3.1). After
adjusting for maternal age, preterm birth, parity, sex, race, maternal education, diabetic
status, alcohol and tobacco use, the likelihood of developing any congenital anomaly was
not significant across water service strata (p>0.05). Only tobacco use was found to increase
the likelihood of an anomaly (Adjusted OR: 2.6; 95%CI: 1.1–5.9). Furthermore, the
incidence of congenital anomalies for each water service category was not statistically
significantly different from the national incidence of 3% (p>0.05). Diagnosis-specific
anomalies are provided along with crude odds ratios (Figure 1). Small frequency counts did
not permit additional adjustment.
Labor and Delivery Complications
53 of 168 (31.5%) LHWA Only mothers developed complications associated with labor and
delivery whereas 491 of 1171 (41.9%) mothers developed complications in the No LHWA
water service category (Adjusted OR: 0.65, 95% CI: 0.46–0.92). 75 of 209 (35.9%) mothers
had complications in the Partial LHWA (Adjusted OR: 0.79, 95%: CI: 0.57–1.1). Overall,
LHWA Only births were associated with a decreased likelihood of complications (p=0.016)
in comparison to No LHWA births. In the adjusted model, multiparous mothers were
associated with a significantly decreased likelihood of developing one or more
complications (Adjusted OR: 0.47, 95% CI: 0.38 – 0.60) compared to primiparous mothers.
Additionally, mothers aged 40 years and older had a tendency to be associated with an
increased likelihood of complications, but this association was not significant in our model
(Adjusted OR: 2.0, 95% CI: 0.96 – 4.2).
Odds ratios for specific diagnoses are reported (Figure 2). LHWA Only mothers had an
increased likelihood of being diagnosed with dysfunctional labor in comparison to No
LHWA mothers (Crude OR: 5.3 95% CI: 1.2–24), but the number of cases was small
(NLHWA Only = 3; NNo LHWA =2). No association between dysfunctional labor and mothers
within the Partial LHWA category was observed. Both LHWA Only and Partial LHWA
mothers had significantly decreased likelihoods of developing other labor and delivery
complications not specifically categorized by the ODH dataset (Crude OR: 0.57, 95% CI:
0.38–0.85; Crude OR: 0.51, 95% CI: 0.35–0.74, respectively).
Maternal Risk Factors
63 of 168 (37.5%) LHWA Only mothers had one or more risk factors commonly associated
with potentially adverse pregnancy outcomes in comparison to 460 of 1171 (39.3%) mothers
residing within the No LHWA water service area (Adjusted OR: 0.94, 95%CI: 0.67–1.3). 72
of 209 (34.4%) mothers within Partial LHWA communities had similar risk factors
(Adjusted OR: 0.74 95%CI: 0.53–1.0). In the adjusted model, which was adjusted for
maternal age, race, maternal education, parity, smoking and alcohol use, the cumulative
likelihood of maternal risk factors across water service strata was not significantly different
(p>0.05). Mothers aged 30 to 34 years and mothers aged 40 years and older were associated
with an overall increased likelihood of developing any risk factor (Adjusted OR: 1.5,
95%CI: 1.1–2.0; Adjusted OR: 3.5, 95% CI: 1.6–7.5) as compared to mothers 25 to 29 years
of age. Additionally, mothers within the LHWA had a significant increase in the likelihood
of anemia compared to mothers outside the LHWA (Crude OR: 11, 95%CI: 1.8–64), but the
number of reported cases was small (NLHWA Only = 3; NNo LHWA =2). A modest increase in
the likelihood of eclampsia was also observed among No LHWA mothers, but the increase
was not statistically significant (Crude OR: 7.0, 95% CI: 0.99–50). Mothers residing within
the Partial LHWA also had a significantly decreased risk of small for gestational age (SGA)
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compared to the No LHWA mothers (Crude OR: 0.14 95%CI: 0.02–0.99). Odds ratios and
individual risk factors are reported (Figure 3).
DISCUSSION
Increased PFOA exposure, as assessed by water service category, was not associated with an
increased likelihood of congenital anomalies (individually or in aggregate). Additionally, the
cumulative incidence of anomalies in any of the water service categories was not
significantly different from the national incidence of 3%. Large point estimates were
observed for diagnose-specific crude odds ratios (e.g. club foot, Down Syndrome, etc.), but
these estimates were not precise on account of small frequencies and none reached the level
of statistical significance. In the fully adjusted model only smoking was found to be
positively associated with a greater likelihood of anomaly development, which is consistent
with published reports on the effect of tobacco use during pregnancy [48].
The overall likelihood of labor and delivery complications was significantly lower among
LHWA Only mothers by 7.8% to 54.3% (95% CI), as compared to mothers within the No
LHWA service category. No difference in the likelihood of complications was observed
between mothers in the Partial and No LHWA strata. In the adjusted model, multiparous
women had a reduced likelihood of experiencing a complication as compared to primiparous
women. Differences in the cumulative incidences of complications among primiparous and
multiparous women were in part the result of cephalopelvic disproportion, which is a
common presentation in first time mothers. Mothers within communities partially serviced
by the LHWA had a significantly decreased risk of small for gestational age (SGA) as
compared to No LHWA mothers (Crude OR: 0.14 95%CI: 0.02–0.99), but no equivalent
reduction was seen among LHWA Only mothers. In the adjusted model for risk factors, 30–
34 year-old mothers and mothers aged 40 years and above had a significantly greater
likelihood of having a risk factor as compared to mothers aged 25–29 years. This finding
mirrored the tendency for mothers aged 40 and above to also have a greater likelihood of
labor and delivery complications. These results were not unexpected since increased
maternal age has long been established as a risk factor for many complications associated
with pregnancy [49].
Two statistically significant adverse associations between water service category and
outcome were observed in our analysis. Mothers residing within the LHWA Only water
service area had a statistically significant increase in the likelihood of anemia as compared
to LHWA Only mothers, but the number of reported cases was very small (NLHWA Only= 2;
NNo LHWA = 3) and no relationship was observed for anemia within the Partial LHWA.
Similarly, LHWA Only mothers had a significant increase in the likelihood of dysfunctional
labor. Again, the number of reported cases was small (NLHWA Only = 3, NNo LHWA = 4) and
no similar increase was observed among mothers in the Partial LHWA.
Given the low frequency of events, broad confidence intervals, inability to adjust for
confounding and the absence of a potential dose-response relationship, the veracity of these
associations is not certain. With respect to anemia, our finding may represent a statistical
aberration since the hematological parameters indicative of this diagnosis have not been
reported in either murine or primate toxicological assessments [11–12,50]. Additionally,
neither our previous serological analysis of specimens taken from LHWA residents nor any
of the major occupational cohort studies of workers within the fluoropolymer manufacturing
industry detected an association between PFOA exposure and reduced red blood cell count
or lowered hemoglobin levels [51–54]. Nevertheless, we do not necessarily dismiss a
potential biologic basis for our findings, particularly since no human investigation has
examined these hematological parameters during pregnancy when the effect of PFOA
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exposure may be compounded by the inherent risk of anemia resulting from plasma volume
expansion and increased iron demands of the fetus [55–56]. Furthermore, PFOA exposure in
the mouse is associated with reduced transferrin gene expression [57] and at least one
occupational study of PFOA observed an association between PFOA exposure and altered
serum iron levels [54]. In light of these findings, we conclude that additional research is
required to further assess this possible association.
For dysfunctional labor, a potential physiologic association with increased PFOA exposure
is less apparent. Though recent research suggests that myometrial lactic acidosis and a
decrease in oxygen saturation may lead to inefficient uterine contractions, there is nothing in
the literature to suggest an association between acidosis and PFOA in animal studies [58].
Moreover, the diagnosis of dysfunctional labor applies more broadly to several etiologies
encompassing cervical, fetal, uterine and iatrogenic complications. Since it is not certain
which of these etiologies were implicated in the few cases (N=3) of dysfunctional labor
occurring in the No LHWA water service category, it impossible to assess whether they may
be associated with a common causative agent.
Lastly, we note that the C8 Science Project observed a modestly elevated risk associated
with PFOA exposure and self-reported cases of preeclampsia in residents of the LHWA who
submitted serum samples between 2005 and 2006 [39]. We report a similar finding with
respect to the incidence of eclampsia in our study, which trended higher in LHWA Only
area mothers. However, this trend did not reach the level of statistical significance and the
number of reported cases was quite small (NLHWA Only= 2; NNo LHWA = 2).
Overall, our failure to detect an association between PFOA and the majority of birth or
pregnancy outcomes is consistent with expectations based on experimental animal studies.
Growth and developmental delays observed in mice were noted only at serum PFOA levels
that were orders of magnitude greater than the levels observed in LHWA residents without
occupational exposure [11–12]. Though highly exposed in comparison to the general U.S
population, the levels of serum PFOA among residents serviced by the LHWA may not be
sufficiently high to affect birth outcomes. Nonetheless, caution is warranted when
extrapolating the results of murine toxicological studies to human populations particularly
since the serum half-life of PFOA differs dramatically between species.
To correlate our outcomes with PFOA, we considered population PFOA exposure to be
highest among zip codes exclusively serviced by the LHWA, intermediate in zip codes
partially serviced by the LHWA and lowest in zip codes not serviced by the LHWA.
Although the robustness of our methodology has been demonstrated by its ability to identify
known predictors of birth outcome and to yield results concordant with studies that directly
measured serum PFOA in the same population, it has potential limitations. In particular, the
lack of individual exposure levels may introduce exposure misclassification (resulting from
the consumption of drinking water outside LHWA supply areas, the use of bottled water or a
home filter and the mobility of pregnant women) into our study. Mothers residing outside
the LHWA service area may have consumed contaminated water at work or during critical
windows of fetal development when the impact of that exposure would be most significant.
Misclassification of these mothers into the No LHWA water service category would
potentially bias our associations towards the null. Although mobility data are not available,
the results of our prior investigations regarding PFOA exposure in the LHWA service area
suggest that misclassification resulting from filtered or bottled water use may be minimized
since the vast majority of LHWA residents consumed some public water (82% consumed
public water exclusively) and had serum PFOA levels well above background levels for the
general US population. Our previous studies also revealed that the exclusive use of bottled
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water was small (3%) and that individuals who utilized a carbon water filter had only mild
decreases in their serum PFOA levels (25%) [33,52].
We also must consider the possibility that the use of a data set with live born neonates may
skew our conclusions regarding the association between PFOA and congenital anomalies. If
exposed neonates were more likely to develop congenital defects, and if those defect
resulted in spontaneous or elective termination of the pregnancy early in gestation, then the
exclusion of stillborn neonates from the data set could potentially bias our associations
towards the null. Nevertheless, there is no indication that stillborn rates vary within the
water service categories Washington County. Furthermore, murine models pregnancy loss
was only observed at the highest levels of exposures (40ppm) which were far greater than
the concentrations of PFOA observed in the LHWA population [10–12].
Finally, the ODH database may be subject to reporting error; however, almost all births
occurred in four local community hospitals that service residents from all zip codes in
Washington County. If reporting errors do exist in the data set, we have no reason to believe
that they would not be randomly distributed among water service categories and bias the
results in favor of a particular association. Moreover, while the fidelity of the ODH data set
with respect to the reporting of congenital anomalies, maternal risk factors and labor and
delivery complications has not been assessed, the ODH observed a 90% congruence
between the reporting of birth weight on birth certificates and medical records and a 60%
congruence for the reporting of gestational age [59]. We have no reason to believe that the
reporting of the outcomes used in this investigation should be any less congruent than that of
birth weight or gestational age.
In summary, our findings suggest that that PFOA is not associated with an increased
incidence of congenital anomalies and most labor and delivery complications and maternal
risk factors. Further investigation is required to assess the validity of the reported
associations between anemia, dysfunctional labor and PFOA.
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TABLE 1
Mean PFOA Levels (μg/L) in Public Water Supplies for Washington County, Ohio
Public Water Facility Mean† (±SD), Median (Range) PFOA (μg/L) Dates of Sampling PFOA Plasma Sampling* Median (μg/L)
LHWA 6.78 (4.2) 5.7 (1.7 – 17.1) 2002 – 2005 132.5 (0.6 – 22,412)
Belpre 0.21 (0.027) 0.22 (0.17 – 0.24) 2002 – 2005 27.1 (0.5 – 7,932)
Marietta 0.0065 (0.0074) 0.0049 (0 – 0.017) 2007 -
Warren 0.007 (0.012) 0.0 (0.0 – 0.021) 2007 -
†
This value is the average and median of PFOA levels in each of the production wells of the indicated public water facility, as measured by the
Ohio State Department of Environmental Protection
*
From the C8 Science Project [1–2]
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TABLE 2
Maternal and Neonatal Demographic Characteristics by Water Service Category
N, %
LHWA Only (N=168) Parital LHWA (N=209) No LHWA (N=1171)
Infant Sex
 Male 73 (43.5%) 109 (52.2%) 591 (50.5%)
 Female 95 (56.5%) 100 (47.8%) 580 (49.5%)
Race
 White 167 (99.4%) 202 (96.7%) 1143 (97.6%)
 Black 0 (0.0%) 6 (2.9%) 13 (1.1%)
 Other 1 (0.6%) 1 (0.4%) 15 (1.3%)
Maternal Education
 < High School 12 (7.1%) 28 (13.4%) 147 (12.5%)
 High School Degree 63 (37.5%) 70 (33.5%) 446 (38.2%)
 College Degree 86 (51.1%) 102 (48.8%) 552 (44.5%)
 Advanced Degree 7 (4.2%) 9 (4.3%) 54 (4.6%)
Parity
 Primiparous 68 (40.5%) 85 (40.7%) 529 (45.2%)
 Multiparous 100 (59.5%) 124 (59.3%) 542 (54.8%)
Smoking Status During Pregnancy
 Smoker 33 (19.6%) 38 (18.2%) 258 (22.0%)
 Non-Smoker 135 (80.4%) 171 (81.8%) 913 (78.0%)
Alcohol Use During Pregnancy
 Yes 0 (0.0%) 1 (0.5%) 5 (0.4%)
 No 168 (100%) 208 (99.5%) 1166 (99.6%)
Diabetic Status
 Diabetic 4 (2.4%) 7 (3.4%) 39 (3.3%)
 Non Diabetic 164 (97.6%) 202 (96.6%) 1132 (96.7%)
Mean ± SD
Mean Maternal Age (Years ± SD) 26.9 ± 4.9 26.6 ± 6.3 26.0 ± 5.5
Mean Gestation (Weeks ± SD) 38.3 ± 2.0 38.1 ± 2.1 38.4 ± 2.5
Mean Birth Weight (Grams ± SD) 3276 ± 422 3278 ± 461 3264 ± 569
Differences in proportions or means are not significant (p>0.05) across water service categories for all characteristics.
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